Sme viac ako distribútor špeciálneho zdravotného materiálu.

 

 

 

 

abbott logo

Abbott má vedúce postavenie v liečbe cievnych ochorení aj vďaka tomu, že kombinuje najnovšie zdravotnícke zariadenia so špičkovými farmaceutickými prípravkami. Akvizíciou spoločnosti St Jude Medical navyše získal komplexné portfólio pre liečbu srdcovo-cievnych ochorení.

www.abbottvascular.com

 

MEDITRADE KONTAKT PRE INTERVENČNÚ KARDIOLÓGIU

Andrea Frisík

Marta Furdiková

Ladislav Lukáč

AV - DES (Liekom poťahované stenty)

Liekom poťahované stenty XIENCE

  • 10 ročná záruka bezpečnosti a účinnosti
  • dvojnásobne viac implantácií ako ktorýkoľvek iný DES
  • 9 000 000 implantovaných Xience v roku 2016

Viac informácií o bezpečnosti Xience >

 

 

Xience Sierra - aktuálne na Slovensku dostupný DES

 

xience sierra abbott vascular

NEW XIENCE SIERRA STENT DESIGN

The new XIENCE Sierra Stent Design, with Slim Flex Technology, has a lower crossing profile1 and greater post-dilatation expansion

NEW STENT DELIVERY SYSTEM FOR COMPLEX CASES

Design innovations built to provide the flexibility, crossability, and pushability needed for even the most complex cases

SLIM

Lowest crossing profile of any DES on the market1

STRONG

Greatest longitudinal strength of any DES, best stent retention on the market, and robust radial strength1

PRECISE

100% accurate mid-marker placement with zero shortening for precise stent placement2

 

Xience Sierra Stent

large vessels

LARGE VESSELS

  • Post-dilatation up to 5.5mm3
  • Superior coating integrity, even at max expansion4
  • Zero shortening2

xience sierra side branch access

SIDE BRANCH ACCESS

  • Largest side branch access in workhorse sizes4
  • Stent design maintains integrity even when cell is opened4

xience sierra radial access

RADIAL ACCESS

  • Unsurpassed pushability: Requires less force to cross lesions6
  • 5 French compatible
  • Lowest crossing profile of any DES4

xience sierra radial access

CTO

  • True Center Tip designed to succeed in CTOs4
  • Lowest crossing profile of any DES4
  • The only CTO-indicated stent
  • Proven safety in CTOs5

xience sierra diabetes

DIABETES

  • New long lengths for small vessels
  • Less force needed to cross tight lesions6
  • Proven superior safety and efficacy in diabetic patients7


1. Data on file at Abbott. Comparative claim refers to major drug-eluting stent manufacturers in U.S. market. Crossing profile refers to 3.0 mm diameter size.
2. Refers to 4.0 mm diameter expanded to 5.5 mm.
3. 5.5 mm maximum expansion in 3.5 and 4.0 mm diameter sizes.
4. Data on file at Abbott. Comparative claim refers to major drug-eluting stent manufacturers in U.S. market. Crossing profile refers to 3.0 mm diameter size.
5. EXPERT CTO Trial data demonstrated 1% definite stent thrombosis and 6.3% TLR at 1 year. Kandzari D, et al. “Safety and Effectiveness of Everolimus-Eluting Stents in Chronic Total Coronary Occlusion Revascularization.” JACC 2015.
6. Test performed by and data on file at Abbott. 3.0 mm diameter size tested, compared to XIENCE Alpine®, Synergy™, Resolute Onyx™.
7. Kaul, U., et al. Last Word on DES in Diabetics: Two Year TUXEDO Outcomes, TCT 2016. Tandjung, K; Clinical Outcome of Diabetic and Non-Diabetic Patients Treated With Second-Generation Zotarolimus-Eluting and Everolimus-Eluting DES: A Subgroup Analysis of the TWENTE Trial; TCT 2012. Superiority claim refers to Taxus